Hubert Birner
CIK 1398598 · last filed 2018-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ENTA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MUNCHEN, 2M 80539
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRTO | Director | 140,820 | $25.31 | $3.56M | $3.00M | 6 | 2018-06-11 |
| ARGOS THERAPEUTICS INC (ARGS) Delisted | Director | 97,151 | — | — | $319.0K | 10 | 2017-01-20 |
| ENTA | 10%+ Owner | 1,144,932 | $8.02 | $9.18M | -$17.05M | 1 | 2014-03-07 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | 10%+ Owner | 1,483,672 | $8.37 | $12.42M | $1.25M | 1 | 2014-02-20 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 113,361 | $116.30 | $13.18M | $1.41M | 1 | 2011-08-04 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| PRTO | By TVM Life Science Ventures VI, L.P.(3) | 48,576 | 34.5% | 2014-10-30 |
| By TVM Life Science Ventures VI GmbH & Co. KG | 47,578 | 33.8% | 2014-10-30 | |
| By TVM Life Science Ventures VI, L.P. | 44,665 | 31.7% | 2014-10-30 | |
| Total | 140,820 | |||
| ARGS | Direct | 634 | 0.7% | 2017-01-04 |
| TVM V Life Science Ventures GmbH & Co See footnote |
96,517 | 99.3% | 2016-07-01 | |
| Total | 97,151 | |||
| CNCE | Direct | 1,104,969 | 74.5% | 2014-02-20 |
| By TVM Life Sciences Ventures VI LP | 378,703 | 25.5% | 2014-02-20 | |
| Total | 1,483,672 | |||
| HZNP | TVM Life Science Ventures VI GmbH & Co See FN |
113,361 | 100.0% | 2011-08-04 |
| Total | 113,361 |
Recent Filings · Page 2 of 2
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-04-04 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | +2,734 | $0 | EDGAR |
| 2016-03-16 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Buy (P) | +183,697 | $0 | EDGAR |
| 2015-06-19 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-03 | PRTO | Grant (A) | — | $0 | EDGAR |
| 2014-10-30 | PRTO | Mixed | +1,943,059 | $3.72M | EDGAR |
| 2014-03-07 | ENTA | Sell (S) | −439,334 | -$17.05M | EDGAR |
| 2014-02-20 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | +1,430,575 | $1.25M | EDGAR |
| 2014-02-12 | ARGOS THERAPEUTICS INC (ARGS) Delisted | Mixed | +1,471,091 | $319.0K | EDGAR |
| 2011-08-04 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +899,951 | $2.54M | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).